Baby born with “avoidable” congenital syphilis: experts

InDaily, June 04, 2020

The recent birth of a child in South Australia with congenital syphilis, despite the mother being previously diagnosed and treated for the sexually transmitted infection, has prompted SA Health concern about the quality of the treatment.

[A] public health alert [sent by SA Health] “reminds and advises health practitioners of their responsibilities” in managing syphilis cases and contacts.

General practitioner at not-for-profit sexual health service SHINE SA Amy Moten said the case was “significant” because it was an avoidable outcome.

Changes to Post-Exposure Prophylaxis (PEP) Distribution

SHINE SA,  

SHINE SA will now temporarily provide a full 28-day supply of Post-exposure Prophylaxis (PEP) medication in place of the usual five-day starter pack. This measure has been put in place with the assistance of SA Health to help limit movement during the COVID-19 pandemic.

Prior to the pandemic, clients received a five-day HIV PEP starter pack and then the remaining medication after a follow-up appointment. Clients can now call SHINE SA for a telehealth appointment where our team will guide clients through the process including supply of the medications and blood tests. Follow-up care arrangements will remain in place.

What is PEP?

PEP is a four week long course of medication taken to reduce the risk of HIV infection. It needs to be initiated within 72 hours of possible contact with HIV in order to help prevent the chance of infection. Exposure can occur through unprotected sex or the sharing of needles and other injection equipment.

It’s important that PEP is accessed as soon as possible after you think you may been exposed to HIV. If you are outside of the time-frame you can still contact your local GP or SHINE SA for further assistance.

What are the most common reasons for needing PEP?

  • Sex without a condom or sex where a condom broke or slipped off, with a person who has, or might have, HIV.
  • Sharing needles or syringes with a person who has, or might have, HIV.

How can I find out more?

  • The PEP Hotline is available 24 hours a day on 1800 022 026. The Registered Nurse on the PEP hotline will help assess your needs and indicate where to access PEP near you.
  • To speak to SHINE SA about accessing PEP call 8300 5300.
  • To learn more about PEP you can visit the SAMESH website or call 7099 5300.

From: https://www.shinesa.org.au/changes-to-pep/

HIV and viral hepatitis disclosure [in South Australia] – factsheet

SA Health, updated 2019

Deciding to disclose your HIV or viral hepatitis (hepatitis B or hepatitis C) status is a personal choice. There are few situations where you are legally required to disclose your HIV or viral hepatitis status, however, there may be times when it’s in your best interests to disclose your status even if you are not legally required to do so.

 

Concerns for women after SA closes two centres for surgical abortion

ABC News, 19/09/2019

Two of South Australia’s surgical abortion services have been shut down over the past 18 months, amid community concerns about the impact on women seeking care.

In January, services were relocated from the main abortion provider in the state, the Pregnancy Advisory Centre in Adelaide’s inner-western suburbs, moving all surgical abortions to the Queen Elizabeth Hospital (QEH).

SA Health is now looking at relocating the abortion service permanently to the QEH during the hospital’s redevelopment.

 

 

New report: Surveillance of STIs and Blood-Borne Viruses in South Australia, 2018

Communicable Disease Control Branch, SA Health, July 2019

In 2018, there were 8,556 new notifications of STI and BBV in South Australia. This represents a 3% increase in the number of new notifications compared to notifications received in 2017.

In 2018, there were 6,256 notifications of Chlamydia trachomatis (chlamydia) making this the most commonly notified STI in South Australia. The demographics of people diagnosed with chlamydia have remained relatively stable over the past five
years.

There were no notifications of donovanosis in 2018.

There were 1,288 notifications of gonorrhoea in 2018. The notification rate of gonorrhoea increased from 45 per 100,000 population in 2014 to 74 per 100,000 population in 2017 and 2018. The rate in the Aboriginal population was 813 per 100,000 population in 2018 compared to 55 per 100,000 population in the non-Indigenous population.

There were 203 notifications of infectious syphilis in 2018, the highest number of annual notifications in the past 10 years. The notification rate of infectious syphilis in 2018 was 11.7 per 100,000 population, more than double the rate in 2016 of 5.2 per 100,000 population. In 2018, 88% of notifications were in males, the majority being among men who have sex with men (MSM) (75%). Infectious syphilis remains high in the Aboriginal population. There were no notifications of congenital syphilis in 2018.

There were 39 new diagnoses of human immunodeficiency virus (HIV) infection in 2018. Thirty-two of the 39 notifications were in males (82%). In 2018, 63% of male cases reported male-to-male sex. Six females acquired their infection overseas and one in South Australia.

There were four notifications of newly acquired hepatitis B infection in 2018, below the five year average (2013-2017) of eight cases per year. There were no notifications in the Aboriginal population. There were 254 notifications of unspecified hepatitis B infection reported in 2018, a decrease compared to the five year average (2013-2017) of 325 cases per year. The notification rate has declined in the Aboriginal population over the past five years.

There were 41 notifications of newly acquired hepatitis C in 2018. Sixty-one per cent of cases were males, and 66% were aged 30 years and over. The notification rate of unspecified hepatitis C infection was 22.2 per 100,000 population in 2018, with a
total of 385 notifications in 2018 compared to 465 in 2017.

There were five new diagnoses of hepatitis D infection in 2018, below the five year average (2013-2017) of 9.8 cases per year.

 

Lastest Gay Community Periodic Survey for Adelaide released

Centre for Social Research in Health, UNSW, June 2019

Gay Community Periodic Survey: Adelaide 2018

Authors: Broady, T., Mao, L., Bavinton, B., Jeffries, D., Bartlett, S., Calabretto, H., Narciso, L., Prestage, G., & Holt.

The Adelaide Gay Community Periodic Survey is a cross-sectional survey of gay and homosexually active men recruited at a range of gay community sites in Adelaide, and online throughout South Australia. The major aim of the survey is to provide data on sexual, drug use, and testing practices related to the transmission of HIV and other sexually transmissible infections (STIs) among gay men. The most recent survey, the twelfth in South Australia, was conducted in November and December 2018 to coincide with the Adelaide Feast Festival.

Key points

– The proportion of men who reported ever having been tested for HIV increased from 83% in 2011 to 87% in 2018.

– The percentage of non-HIV-positive men who reported testing for HIV in the 12 months prior to the survey remained stable (and was reported by 71% in 2018), although the percentage reporting three or more HIV tests in the previous year increased (from 11% in 2014 to 22% in 2018).

– The use of HIV treatment by HIV-positive men has remained stable over time (and was reported by 93% of HIV-positive men in 2018). The percentage of men on antiretroviral treatment who reported an undetectable viral load also remained stable (reported by 94% in 2018).

Mobile phone apps remained the most common way that men met male sex partners, reported by 44% in 2018.

– The proportion of men with regular male partners reporting condomless anal intercourse with those partners (CAIR) increased from 55% in 2011 to 65% in 2018.

– The proportion of men with casual male partners reporting condomless anal intercourse with those partners (CAIC) increased from 38% in 2011 to 51% in 2018.

– Most of the recent increase in CAIC appears to be attributable to the growing proportion of HIV-negative men using pre-exposure prophylaxis (PrEP).

STI testing among HIV-negative men has remained stable over time, with 74% reporting any STI test in the year prior to the 2018 survey. The proportion of HIV-positive men reporting any STI test in the previous year decreased from 91% in 2011 to 72% in 2018.

Use of PrEP increased between 2014 and 2018 from 1% to 16% of non-HIV-positive men.